Letter to the Editor

The Prevalence of Hemoglobinopathies in Reference Laboratory of Kermanshah, Western Iran

1. Rahimi Z (2013). Genetic epidemiology, hematological and clinical features of he-moglobinopathies in Iran. Biomed Res Int, 2013:803487.
2. Rahimi Z, Merat A, Gerard N et al (2006). Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum Biol, 78(6):719-31.
3. Rahimi Z, Akramipour R, Nagel RL et al (2006). The beta-globin gene haplotypes associated with Hb D-Los Angeles [be-ta121 (GH4) Glu-->Gln] in Western Iran. Hemoglobin, 30(1):39-44.
4. Rahimi Z, Rezaei M, L Nagel R, Muniz A (2008). Molecular and hematologic analy-sis of hemoglobin Q-Iran and hemoglo-bin Setif in Iranian families. Arch Iran Med, 11(4):382-6.
5. Rahimi Z, Muniz A, Parsian A (2010). De-tection of responsible mutations for beta thalassemia in the Kermanshah Province of Iran using PCR-based techniques. Mol Biol Rep, 37(1):149-54.
6. Hosseini S, Kalantar E, Dorgalaleh A (2014). A long term screening of Iranian populations with thalassemia and hemoglobinopathies. Br Med Bull, 2(4): 669-676.
7. Rahimi Z, Muniz A, Mozafari H (2010). Ab-normal hemoglobins among Kurdish population of Western Iran: hematologi-cal and molecular features. Mol Biol Rep, 37(1):51-57.
Files
IssueVol 48 No 2 (2019) QRcode
SectionLetter to the Editor
DOI https://doi.org/10.18502/ijph.v48i2.842
Keywords
No keywords####

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
RAHIMI Z, NAJAFI S, MOGHOFEHIE L, AMIRI E, VAISI-RAYGANI A, RAHIMI Z. The Prevalence of Hemoglobinopathies in Reference Laboratory of Kermanshah, Western Iran. Iran J Public Health. 2019;48(2):359-361.